2009-03-04 S. 525: Pharmaceutical Market Access and Drug Safety Act of 2009 2009-03-04 S. 525: Pharmaceutical Market Access and Drug Safety Act of 2009 Health Prescription drugs Intergovernmental relations Administrative law and regulatory procedures Government investigations Asia Canada Japan Department of Health and Human Services Health information and medical records Federal preemption Civil actions and liability Medical education Administrative remedies Marketing and advertising Business records User charges and fees Intellectual property Internet and video services Evidence and witnesses Europe Consumer affairs Trade restrictions Product safety and quality Retail and wholesale trades Medical tests and diagnostic methods Fraud offenses and financial crimes Consumer credit Federal Trade Commission (FTC) Food and Drug Administration (FDA) Contracts and agency Oceania Australia European Union New Zealand Switzerland introduced S. 525: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 2009-03-04 Sponsor introductory remarks on measure. (CR S2780-2781) 2009-03-05 111 S. 525: Pharmaceutical Market Access and Drug Safety Act of 2009 (111th Congress) 525 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 (111th Congress) H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232: Pharmaceutical Market Access and Drug Safety Act of 2009 (111th Congress) S. 1232: Pharmaceutical Market Access and Drug Safety Act of 2009 s Pharmaceutical Market Access and Drug Safety Act of 2009 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. SenateBill LegislativeAction OfficialTitle ShortTitle